USPTO serial 79090386
SANTARIS PHARMA A/S
Reviewed by CopyMark Law Group
Reg. 4069179Status 404
- Filing date
- Status date
- Registration date
- Dec 13, 2011
- Examiner
- PILARO, MARK F
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SANTARIS PHARMA A/S?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. David Galin
M. David Galin Renner, Otto, Boisselle & Sklar LLP1621 Euclid Avenue, 19th FloorCleveland, OH 44115UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary preparations, namely, preparations comprising nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs for treating of diseases, disorders and afflictions except for preparations directed to gastrointestinal diseases and disorders | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, research and design in the field of nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs except for preparations directed to gastrointestinal diseases and disorders; development of medical and biomedical products and preparations, namely, in the field of nucleotides, nucleotide analogs, oligonucleotides and oligonucleotide analogs except for preparations directed to gastrointestinal diseases and disorders; biomedical and biotechnological analysis of RNA expression and protein expression, and biomedical and biotechnological research; biochemical and molecular biological analysis of RNA expression and protein expression; scientific, biotechnological and biomedical consultancy, namely, in the field of disease related RNA expression and protein expression; in vivo and in vitro pre-clinical testing of potential pharmaceutical, medical and veterinary preparations, methods and products except for preparations directed to gastrointestinal diseases and disorders; analysis of therapeutic effects of chemical, pharmaceutical, medical and veterinary preparations, namely, analysis in the field of medicine and veterinary medicine except for preparations directed to gastrointestinal diseases and disorders | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks owned by Santaris Pharma A/S
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SANTARIS PHARMA A/S
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 27, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 27, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 17, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 23, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 23, 2019 | INPC | INVALIDATION PROCESSED | — |
| Mar 20, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 20, 2018 | C71T | CANCELLED SECTION 71 | — |
| Dec 13, 2016 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 7, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 11, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 23, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 23, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 17, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Mar 13, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 13, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 27, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 7, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 7, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 24, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 23, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 23, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 23, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 23, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 13, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 30, 2011 | ALIE | ASSIGNED TO LIE | — |
| Jun 20, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 22, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 4, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 4, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 3, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 31, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 30, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 28, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 28, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 23, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |